- Home
- ILMN vs DECK Comparison
ILMN vs DECK Comparison
Compare ILMN & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- DECK
- Stock Information
- Founded
- ILMN 1998
- DECK 1973
- Country
- ILMN United States
- DECK United States
- Employees
- ILMN N/A
- DECK N/A
- Industry
- ILMN Medical Specialities
- DECK Shoe Manufacturing
- Sector
- ILMN Health Care
- DECK Consumer Discretionary
- Exchange
- ILMN Nasdaq
- DECK Nasdaq
- Market Cap
- ILMN 13.1B
- DECK 15.2B
- IPO Year
- ILMN 2000
- DECK 1993
- Fundamental
- Price
- ILMN $100.80
- DECK $106.21
- Analyst Decision
- ILMN Buy
- DECK Buy
- Analyst Count
- ILMN 16
- DECK 22
- Target Price
- ILMN $126.88
- DECK $144.56
- AVG Volume (30 Days)
- ILMN 2.3M
- DECK 2.9M
- Earning Date
- ILMN 08-05-2025
- DECK 07-24-2025
- Dividend Yield
- ILMN N/A
- DECK N/A
- EPS Growth
- ILMN N/A
- DECK 30.25
- EPS
- ILMN N/A
- DECK 6.33
- Revenue
- ILMN $4,337,000,000.00
- DECK $4,985,612,000.00
- Revenue This Year
- ILMN N/A
- DECK $10.38
- Revenue Next Year
- ILMN $3.11
- DECK $7.85
- P/E Ratio
- ILMN N/A
- DECK $16.78
- Revenue Growth
- ILMN N/A
- DECK 16.27
- 52 Week Low
- ILMN $68.70
- DECK $93.72
- 52 Week High
- ILMN $156.66
- DECK $223.98
- Technical
- Relative Strength Index (RSI)
- ILMN 81.33
- DECK 49.40
- Support Level
- ILMN $88.68
- DECK $102.09
- Resistance Level
- ILMN $95.99
- DECK $109.08
- Average True Range (ATR)
- ILMN 2.91
- DECK 2.95
- MACD
- ILMN 0.93
- DECK 0.86
- Stochastic Oscillator
- ILMN 97.37
- DECK 75.17
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About DECK Deckers Outdoor Corporation
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2025, Ugg and Hoka accounted for 51% and 45% of total sales, respectively. The firm also markets niche brands Teva and Ahnu. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and about 180 company-operated stores. It generated 64% of its fiscal 2025 sales in the United States.